Sirolimus
Concept
Vocabulary Service
Overview
subject area of
-
A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041) Academic Article
-
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas Conference Paper
-
A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors Academic Article
-
Adverse event management in patients with advanced cancer receiving oral everolimus: focus on breast cancer Academic Article
-
An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy Academic Article
-
CCI-779 Wyeth. Academic Article
-
Characterisation of the lung toxicity of the cell cycle inhibitor temsirolimus Academic Article
-
Clinical and toxicity predictors of response and progression to temsirolimus in women with recurrent or metastatic endometrial cancer Academic Article
-
Combined mTOR Inhibition and OX40 Agonism Enhances CD8+ T Cell Memory and Protective Immunity Produced by Recombinant Adenovirus Vaccines Academic Article
-
Combined mTOR inhibition and OX40 agonism enhances CD8(+) T cell memory and protective immunity produced by recombinant adenovirus vaccines. Academic Article
-
Defining vascular anomaly phenotypes in children based on a systematic literature search: A critical step in developing a single severity score for interventional clinical trials Academic Article
-
Drug evaluation: AP-23573--an mTOR inhibitor for the treatment of cancer. Academic Article
-
E2F7 promotes mammalian target of rapamycin inhibitor resistance in hepatocellular carcinoma after liver transplantation Academic Article
-
Effect of Everolimus on Bone Marker Levels and Progressive Disease in Bone in
BOLERO-2 Academic Article
-
Effect of FKBP65, a putative elastin chaperone, on the coacervation of tropoelastin in vitro Academic Article
-
Effect of visceral metastases on the efficacy and safety of everolimus in postmenopausal women with advanced breast cancer: Subgroup analysis from the BOLERO-2 study Academic Article
-
Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis Academic Article
-
Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer Academic Article
-
Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2 Academic Article
-
Everolimus, when combined with exemestane, adds toxicity with minimal benefit for women with breast cancer Academic Article
-
Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Disease Academic Article
-
Glucose transporter expression in L6 muscle cells: Regulation through insulin- and stress-activated pathways Academic Article
-
Health-related quality of life and disease symptoms in postmenopausal women with HR+, HER2−advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy Academic Article
-
Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial Academic Article
-
Health-related quality-of-life outcomes of sirolimus-treated kidney transplant patients after elimination of cyclosporine A: results of a 2-year randomized clinical trial1 Conference Paper
-
Immunosuppression without calcineurin inhibition: optimization of renal function in expanded criteria donor renal transplantation Academic Article
-
Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2 Academic Article
-
Intragraft CD11b+IDO+ Cells Mediate Cardiac Allograft Tolerance by ECDI-Fixed Donor Splenocyte Infusions Academic Article
-
Long-term benefit using DES in STEMI patients. Academic Article
-
Mechanisms coordinating ribosomal protein gene transcription in response to stress Academic Article
-
Metastatic renal cell cancer treatments: An indirect comparison meta-analysis Academic Article
-
Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis Academic Article
-
Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management Academic Article
-
Opportunities for enhancing the care of older patients with ST-elevation myocardial infarction presenting for primary percutaneous coronary intervention: Rationale and design of the SAFE-STEMI for Seniors trial Academic Article
-
PCI with drug-eluting stents ≤ 12 months before surgery was linked to increased MI and cardiac death after surgery Academic Article
-
Paclitaxel Versus Sirolimus Stents in Diabetic and Nondiabetic Patients Academic Article
-
Phase I study of vinblastine and temsirolimus in pediatric patients with recurrent or refractory solid tumors: Canadian Cancer Trials Group Study IND.218 Academic Article
-
Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group Academic Article
-
Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer Academic Article
-
Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199) Academic Article
-
Randomized Phase II Study Comparing Two Schedules of Everolimus in Patients With Recurrent/Metastatic Breast Cancer: NCIC Clinical Trials Group IND.163 Conference Paper
-
Rapamycin does not prevent increases in myofibrillar or mitochondrial protein synthesis following endurance exercise Academic Article
-
Rapamycin has a beneficial effect on controlling epilepsy in children with tuberous sclerosis complex: results of 7 children from a cohort of 86 Academic Article
-
Rapamycin inhibits transforming growth factor β-induced peritoneal angiogenesis by blocking the secondary hypoxic response Academic Article
-
Safety Analysis of Four Randomized Controlled Studies of Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Mantle Cell Lymphoma Academic Article
-
Safety and Efficacy of Everolimus With Exemestane vs. Exemestane Alone in Elderly Patients With HER2-Negative, Hormone Receptor–Positive Breast Cancer in BOLERO-2 Academic Article
-
Sirolimus Therapy after Early Cyclosporine Withdrawal Reduces the Risk for Cancer in Adult Renal Transplantation Academic Article
-
Sirolimus and low-dose tacrolimus with antibody induction in kidney transplantation: preliminary results of a pilot study Conference Paper
-
Sirolimus and mTORC1: centre stage in the story of what makes muscles bigger? Academic Article
-
Sirolimus is not always responsible for new-onset proteinuria after conversion for chronic allograft nephropathy Academic Article
-
Sirolimus-Based Therapy Following Early Cyclosporine Withdrawal Provides Significantly Improved Renal Histology and Function at 3 Years Academic Article
-
Surgical biology for the clinician: vascular effects of immunosuppression. Academic Article
-
Targeted therapy for metastatic renal cell carcinoma Academic Article
-
Temsirolimus in combination with carboplatin and paclitaxel in patients with advanced solid tumors: a NCIC-CTG, phase I, open-label dose-escalation study (IND 179) Academic Article
-
The mTORC Pathway in the Antiphospholipid Syndrome Academic Article
-
Very Late Stent Fracture Associated With a Sirolimus-eluting Stent Academic Article